Moatable Declares Special Cash Dividend of US$0.6057 per ADS and Ex-Dividend Date
PHOENIX, March 5, 2025 /PRNewswire/ -- Moatable, Inc. (OTC Pink: MTBLY) ("Moatable" or the "Company"), an operator of several US-based SaaS businesses, today announced that its Board of Directors has declared a special cash dividend (the "Special...
QNAP Empowers Professionals with TS-h1277AFX All-flash NAS, Engineered for Intensive Creative and Virtual Workloads
TAIPEI, March 5, 2025 /PRNewswire/ -- QNAP® Systems, Inc. , a leading innovator in computing, networking, and storage solutions, has unveiled the TS-h1277AFX, a 12-bay tower all-flash NAS designed to meet the rigorous demands of multimedia...
Baidu Announces Proposed Offering of CNY-denominated Senior Notes
BEIJING, March 5, 2025 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)), ("Baidu" or the "Company"), a leading AI company with strong Internet foundation, today announced that it proposes to offer...
MWC Barcelona 2025 Fibocom Debuts Compact, Low-Power Cat.M Module MQ780-GL Powered by Qualcomm Modem-RF
BARCELONA, Spain, March 5, 2025 /PRNewswire/ -- Fibocom (Stock code:300638), a global leading provider of AIoT solutions and wireless communication modules, has unveiled its new MQ780-GL Cat.M module embedded with the Qualcomm® E51 4G Modem-RF....
MWC Barcelona 2025: Fibocom Launches Qualcomm X85/X82 5G Modem-RF-Powered 5G Modules, Enhancing FWA AI Capabilities
BARCELONA, Spain, March 4, 2025 /PRNewswire/ -- Fibocom (Stock code:300638), a global leading provider of AIoT solutions and wireless communication modules, announced the launch of its new 5G modules and solutions based on Qualcomm Technologies,...
CBAK Energy to Participate at Upcoming Jefferies 6th Asia Forum in Hong Kong
DALIAN, China, March 3, 2025 /PRNewswire/ -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy", or the "Company"), a leading lithium-ion battery manufacturer and electric energy solution provider, today announced its participation in the...
Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics
First ever head-to-head comparison of gut microbiome changes associated with ibezapolstat (IBZ) to other anti-CDI antibiotics in a germ-free mouse model Changes in alpha and beta microbiome diversities following IBZ treatment were less pronounced...
Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma
SAN FRANCISCO and SUZHOU, China, March 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...
Metanoia Unveils MT5824: The World's Lowest Power, Smallest Footprint 4T4R O-RU Solution
TAIPEI, Feb. 27, 2025 /PRNewswire/ -- At Mobile World Congress (MWC) 2025, Metanoia will showcase the MT5824 chipset, a groundbreaking 5G SoC with future-proof Software Defined Radio (SDR) architecture, open-source flexibility, and industry-leading...
Akeso Announces First ADC Drug Clinical Trial, Marking a New Era for "IO 2.0 + ADC" Strategy
HONG KONG, Feb. 27, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment of advanced malignancies in Australia. AK138D1, a self-developed and...